These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 29028259)

  • 1. Stem Cell Transplantation for Frailty.
    Le Couteur DG; Anderson RM; Newman AB; de Cabo R
    J Gerontol A Biol Sci Med Sci; 2017 Oct; 72(11):1503-1504. PubMed ID: 29028259
    [No Abstract]   [Full Text] [Related]  

  • 2. Application of mesenchymal stem cell therapy for aging frailty: from mechanisms to therapeutics.
    Zhu Y; Ge J; Huang C; Liu H; Jiang H
    Theranostics; 2021; 11(12):5675-5685. PubMed ID: 33897874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meeting report: Adult Mesenchymal Stem Cells in Regenerative Medicine conference, August 2007.
    Rao M
    Stem Cells; 2007 Nov; 25(11):2973-4. PubMed ID: 17885075
    [No Abstract]   [Full Text] [Related]  

  • 4. Practice of postponing human aging.
    Kristjuhan U
    Rejuvenation Res; 2010; 13(2-3):356-8. PubMed ID: 20370496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesenchymal Stem Cells as a Biological Drug for Heart Disease: Where Are We With Cardiac Cell-Based Therapy?
    Sanina C; Hare JM
    Circ Res; 2015 Jul; 117(3):229-33. PubMed ID: 26185208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of dental stem cells in regenerative dentistry: a possible alternative.
    Rodríguez-Lozano FJ; Moraleda JM
    Transl Res; 2011 Dec; 158(6):385-6. PubMed ID: 22061045
    [No Abstract]   [Full Text] [Related]  

  • 7. Frailty and Rejuvenation with Stem Cells: Therapeutic Opportunities and Clinical Challenges.
    Sun XL; Hao QK; Tang RJ; Xiao C; Ge ML; Dong BR
    Rejuvenation Res; 2019 Dec; 22(6):484-497. PubMed ID: 30693831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ageing: Develop models of frailty.
    Howlett SE; Rockwood K
    Nature; 2014 Aug; 512(7514):253. PubMed ID: 25143102
    [No Abstract]   [Full Text] [Related]  

  • 9. The rejuvenation of aged stem cells for cardiac repair.
    Ludke A; Li RK; Weisel RD
    Can J Cardiol; 2014 Nov; 30(11):1299-306. PubMed ID: 25092405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rationale and design of the allogeneiC human mesenchymal stem cells (hMSC) in patients with aging fRAilTy via intravenoUS delivery (CRATUS) study: A phase I/II, randomized, blinded and placebo controlled trial to evaluate the safety and potential efficacy of allogeneic human mesenchymal stem cell infusion in patients with aging frailty.
    Golpanian S; DiFede DL; Pujol MV; Lowery MH; Levis-Dusseau S; Goldstein BJ; Schulman IH; Longsomboon B; Wolf A; Khan A; Heldman AW; Goldschmidt-Clermont PJ; Hare JM
    Oncotarget; 2016 Mar; 7(11):11899-912. PubMed ID: 26933813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stem Cell Aging and Age-Related Cardiovascular Disease: Perspectives of Treatment by Ex-vivo Stem Cell Rejuvenation.
    Madonna R; Engel FB; Davidson SM; Ferdinandy P; Gorbe A; Sluijter JP; Van Laake LW
    Curr Drug Targets; 2015; 16(8):780-5. PubMed ID: 25479545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allogeneic Human Mesenchymal Stem Cell Infusions for Aging Frailty.
    Golpanian S; DiFede DL; Khan A; Schulman IH; Landin AM; Tompkins BA; Heldman AW; Miki R; Goldstein BJ; Mushtaq M; Levis-Dusseau S; Byrnes JJ; Lowery M; Natsumeda M; Delgado C; Saltzman R; Vidro-Casiano M; Pujol MV; Da Fonseca M; Oliva AA; Green G; Premer C; Medina A; Valasaki K; Florea V; Anderson E; El-Khorazaty J; Mendizabal A; Goldschmidt-Clermont PJ; Hare JM
    J Gerontol A Biol Sci Med Sci; 2017 Oct; 72(11):1505-1512. PubMed ID: 28444181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. About stem cell research in dentistry: many doubts and too many pitfalls still affect the regenerative dentistry.
    Tatullo M
    Int J Med Sci; 2018; 15(14):1616-1618. PubMed ID: 30588184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesenchymal Stem/Stromal Cells and Their Derivates in Acute Diseases: Emergency in the Post-COVID-19 Times.
    Vizoso FJ; Fernández-Francos S; Eiro N
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanotechnology for mesenchymal stem cell therapies.
    Corradetti B; Ferrari M
    J Control Release; 2016 Oct; 240():242-250. PubMed ID: 26732556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stem cells versus senescence: the yin and yang of cardiac health.
    Behfar A; Terzic A
    J Am Coll Cardiol; 2015 Jan; 65(2):148-50. PubMed ID: 25593055
    [No Abstract]   [Full Text] [Related]  

  • 17. Inflammation, a common mechanism in frailty and COVID-19, and stem cells as a therapeutic approach.
    Becerra J; Duran I
    Stem Cells Transl Med; 2021 Nov; 10(11):1482-1490. PubMed ID: 34164948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elixir of Life: Thwarting Aging With Regenerative Reprogramming.
    Beyret E; Martinez Redondo P; Platero Luengo A; Izpisua Belmonte JC
    Circ Res; 2018 Jan; 122(1):128-141. PubMed ID: 29301845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Regenerative medicine for anti-aging].
    Ebisawa K; Kagami H; Kato R; Yamada Y; Ueda M
    Nihon Rinsho; 2009 Jul; 67(7):1402-6. PubMed ID: 19591293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attenuation of frailty in older adults with mesenchymal stem cells.
    Florea V; Bagno L; Rieger AC; Hare JM
    Mech Ageing Dev; 2019 Jul; 181():47-58. PubMed ID: 31181214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.